A cholera outbreak in war-ravaged Yemen could infect more than 300,000 people by the end of August, up from nearly 193,000 cases today, the United Nations said Friday.

The Republican majority in the U.S. Senate is about to reveal a new health care bill less brutal than that proposed by the House of Representatives, The Washington Post reported Wednesday.

A famine that was declared in parts of South Sudan four months ago is over, UN aid agencies said Wednesday, but extreme hunger has increased to its highest levels ever across the war-torn country. 

Researchers unveiled new data Tuesday that they said would help better assess breast or ovarian cancer risks in women, identifying the advantages of early detection and lifelong monitoring.

Yoga has connected the world with India, Prime Minister Narendra Modi said Wednesday, as he rolled out his mat along with millions of others across the globe to celebrate the ancient practice.

Enthusiasts across India rose at the crack of dawn, many braving monsoon showers, to mark the third International Yoga Day.

An Indian girl who made international headlines when a rare condition caused her head to swell to more than twice the normal size has died, days before she was to undergo corrective surgery.

It's early morning, just after breakfast, and six-year-old Cayley is wide awake, eagerly anticipating her daily dose of cannabis.

A cholesterol-lowering vaccine has shown promise in mice, said researchers Tuesday who announced they had started early-phase trials to see if it also works in humans.

Scientists have discovered a new antibiotic that is highly effective against bacteria resistant to known antimicrobials, which was found in a soil sample taken in Italy.

As obesity expands waistlines in the Western world, a silent killer linked to the condition nicknamed "human foie gras" is spurring a potential bonanza worth billions for drugs giants.

The disease, formally known as non-alcoholic steatohepatitis (NASH), is caused by a buildup of fat in the liver. It is already the leading ailment cited in requests for liver transplants in the United States, Cecile Rabian of France's Gilead laboratory told AFP.